LCM
NVO

Laurion Capital Management’s Novo Nordisk NVO Stock Holding History

Laurion Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Buy
+44,100
New +$1.89M 0.05% 211

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Laurion Capital Management's NVO Position: Q2 2026 in Review

Laurion Capital Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 1,692 shares worth $81.1K. The stake represents ﹤0.01% of the portfolio and ranks #404 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in NVO as recently as Q3 2025.

Laurion Capital Management first reported a position in NVO in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.62M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Laurion Capital Management held 1,692 shares of Novo Nordisk worth $81.1K as of Q2 2026.
  • Novo Nordisk was a new Laurion Capital Management position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Laurion Capital Management's portfolio in Q2 2026, its #404 holding.
  • Laurion Capital Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 2 quarters since.
  • Laurion Capital Management's Novo Nordisk position peaked at $1.62M in Q3 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.